Exclusive: Express scripts presses for more drug savings with coverage list

Nils Behnke, partner at Bain & Company, is quoted by Reuters on drug pricing trends. Behnke comments, "when you look at the industry as a whole, we will probably see less profitability. Mid-sized companies with a broader portfolio of little products, 'me-too' products - they will have a hard time."